Legal & General Group’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $370K | Sell |
56,864
-3,701
| -6% | -$24.1K | ﹤0.01% | 2523 |
|
|
2025
Q1 | $480K | Buy |
60,565
+2,942
| +5% | +$23.3K | ﹤0.01% | 2408 |
|
|
2024
Q4 | $730K | Buy |
57,623
+1,359
| +2% | +$17.2K | ﹤0.01% | 2333 |
|
|
2024
Q3 | $784K | Buy |
56,264
+1,087
| +2% | +$15.1K | ﹤0.01% | 2315 |
|
|
2024
Q2 | $760K | Buy |
55,177
+1,753
| +3% | +$24.2K | ﹤0.01% | 2286 |
|
|
2024
Q1 | $883K | Sell |
53,424
-67
| -0.1% | -$1.11K | ﹤0.01% | 2233 |
|
|
2023
Q4 | $781K | Sell |
53,491
-239
| -0.4% | -$3.49K | ﹤0.01% | 2284 |
|
|
2023
Q3 | $659K | Buy |
53,730
+4,630
| +9% | +$56.8K | ﹤0.01% | 2327 |
|
|
2023
Q2 | $586K | Buy |
49,100
+46,515
| +1,799% | +$555K | ﹤0.01% | 2409 |
|
|
2023
Q1 | $34.6K | Hold |
2,585
| – | – | ﹤0.01% | 2934 |
|
|
2022
Q4 | $55.6K | Hold |
2,585
| – | – | ﹤0.01% | 2938 |
|
|
2022
Q3 | $52K | Buy |
2,585
+561
| +28% | +$11.3K | ﹤0.01% | 2963 |
|
|
2022
Q2 | $36K | Sell |
2,024
-159
| -7% | -$2.83K | ﹤0.01% | 3069 |
|
|
2022
Q1 | $22K | Buy |
2,183
+1,156
| +113% | +$11.7K | ﹤0.01% | 3210 |
|
|
2021
Q4 | $17K | Hold |
1,027
| – | – | ﹤0.01% | 3322 |
|
|
2021
Q3 | $24K | Buy |
+1,027
| New | +$24K | ﹤0.01% | 3209 |
|